Singapore, Nov. 7 -- Fujifilm Corporation has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognised for its leadership in cancer care and research.

Under this agreement, Fujifilm and the National Cancer Center Japan will collaborate on the development of novel cancer treatment technologies. The research will focus on evaluating the efficacy and targeted delivery of therapeutic agents using Fujifilm's proprietary cyclic peptides containing unnatural amino acidsand antisense nucleic acidsdesigned by the National Cancer Center Research Institute to selectively induce apoptosis in cancer cells.

Fujifilm will develop peptide-nucleic acid conjugate by linking its proprietary cyc...